# Hematolapp — Haematology scores & protocols

> Haematology scores & protocols (iPhone/iPad app by VINICIUS CAMPOS DE MOLLA & CIA LTDA.)

- Source: https://appshunter.io/ios/app/hematolapp/id6829974695 (this page in markdown: same URL + `.md`)
- Developer: [VINICIUS CAMPOS DE MOLLA & CIA LTDA](https://appshunter.io/developer/6829974697)
- Category: Medical, Reference
- Price: Free with in-app purchases
- Age rating: 17+
- Requires: iOS 15.0 · 29 MB
- Languages: American English
- Released: 2026-11-08
- Data updated: 2026-11-18
- User reviews in markdown: https://appshunter.io/ios/app/hematolapp/id6829974695/reviews.md

## What is Hematolapp?

Hematolapp brings together the calculators and reference protocols haematologists use every day — from haem-onc to transplantation and cell therapy. Every score shows its original reference on screen, and every calculation is checked by automated tests against published examples.

FIVE AREAS
• Haem-onc: IPSS-R, IPSS-M, ELTS, DIPSS-plus, MIPSS70, IPI and R-IPI, NCCN-IPI, FLIPI, MIPI, CLL-IPI, R-ISS, tumour lysis, febrile neutropenia.
• Benign haematology: IV iron (Ganzoni), transferrin saturation, Wells, 4Ts, HScore, PLASMIC, DIC, Padua, anticoagulant reversal.
• Transfusion medicine: corrected platelet increment, plasma exchange, cryoprecipitate, ABO compatibility, CD34.
• HCT: HCT-CI, DRI, VOD risk (CIBMTR), HCT-FS, EASIX, day-D guide, busulfan AUC, HLA matching and DSA, acute (MAGIC) and chronic (NIH 2014) GVHD.
• Cell therapy: CRS and ICANS grading (ASTCT), CAR-HEMATOTOX, ICAHT.

REFERENCE PROTOCOLS
Transplant, supportive-care and toxicity protocols based on consensus guidelines (EBMT and other societies), with sources cited.

BUILT FOR THE BEDSIDE
• Works offline.
• English, Portuguese and Spanish.
• Favourites and search across every calculator and protocol.
• No sign-up, no ads, no tracking: what you type stays on the screen and is cleared when you leave it.

NOTICE
For healthcare professionals only. Hematolapp is a decision-support and reference tool; it does not replace clinical judgement or your institution's protocols. Do not enter data that identifies patients.

SUBSCRIPTION
Hematolapp Pro — monthly or yearly, auto-renewing. Payment is charged to your Apple Account and the subscription renews automatically unless cancelled at least 24 hours before the end of the period; manage it in Settings > Subscriptions.
Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Hematolapp Terms: https://hematolapp.com/terms.html
Privacy Policy: https://hematolapp.com/privacy.html

## Pricing and in-app purchases

Base price: Free.

**Subscriptions**

| Subscription | Price | Period |
| --- | --- | --- |
| Monthly | $1.99 | per month |
| Annual | $11.99 | per year |


## Is Hematolapp safe?

Not enough ratings yet to assess Hematolapp.

## Is Hematolapp legit?

Hematolapp has limited verification signals. The AppsHunter Legitimacy Score for Hematolapp is 58 out of 100 points across 7 verification signals from App Store and developer data.

## Recent user reviews (1 of 1)

All indexed reviews: https://appshunter.io/ios/app/hematolapp/id6829974695/reviews.md

### 5/5 — Ótimo e muito completo

*2026-11-10*

Super atualizado, com as evidências embaixo, além de ser fácil de usar. Tem tudo o que eu preciso em um lugar só.

## Version history (last 5 releases)

### 1.12.1 — 2026-11-18

Fix: when you switch units in the calculators, the value you typed is now converted.

### 1.11 — 2026-11-15

• AI: ASH abstracts now come in their own section, apart from SUS, and cited sources become buttons that open the protocol or regimen
• New "CRS + ICANS (CAR-T)" screen: both ASTCT grades and the management for each on one screen
• CRS and ICANS entries with diagnosis (criteria, ICE, differential), onset and duration, and grade-by-grade management checked against the EBMT/EHA consensus
• Therapeutic phlebotomy: tap tool — pick the indication and see target, volume, frequency and how long to continue

### 1.10 — 2026-11-14

• Optional account: sign in with Apple, Google or email to carry your subscription to another device; new accounts get 1 extra month of access. Without an account the app works as before
• More readable cycle sheet: long regimens come out in day ranges and over several pages; send by WhatsApp or email in one tap
• 91 new ALL regimens (GRAALL-2014, CALGB 10403, E1910, GIMEMA ALL2820, PhALLCON, GRAAPH, COG, St. Jude and more), every phase with doses, days and source; protocols name each regimen and link to it and to the cycle sheet
• Transfusion medicine: therapeutic phlebotomy (when to use it, volume and for how long), modified blood components (irradiate, leucodeplete, wash, split) and five legislation entries (Brazilian rules, in Portuguese)
• HCT: four legislation entries (technical regulation, donor, coverage rules and SIGTAP) and the Brazil access entry updated (in Portuguese)
• New-version notice with a dot in Settings

### 1.9 — 2026-11-13

• New look: each area now has its own hand-drawn cell, and the tiles are cleaner, with just the drawing and the name
• Result with a scale: in 14 scores (IPSS-R, MIPSS70, DIPSS, IPI, FLIPI, CLL-IPI, Khorana, Wells, 4Ts, PLASMIC and others) a band shows which category the value falls in and how far the next one is
• AI: your latest conversations are kept on the device and reopening one does not use a question; tables in the answer are now readable on a phone
• Busulfan AUC: three checks against report misreading (curve shape, double reading of the photo and field-by-field confirmation)
• Diffuse large B-cell lymphoma: the ESMO 2026 guideline now sits beside EHA and BSH, in first line and at relapse
• Brazil: rituximab, imatinib, dasatinib and nilotinib as APAC records and CONITEC updated (content in Portuguese)
• iPhone: the screen no longer zooms in by itself when you tap a field

### 1.8 — 2026-11-12

• Vaccination after HCT and CAR-T: the date of each dose from day 0 and a PDF for the patient; the Day-by-day guide shows vaccines month by month
• Studies: the trials that changed practice in each area, with links to the papers (content in Portuguese)
• Transfusion medicine: ASFA 2023 apheresis indications (content in Portuguese)
• ASH 2026: highlighted abstracts by area, from leukemias and lymphomas to MDS, sickle cell, ITP, hemostasis and thrombosis (content in Portuguese)
• AI: also answers from the studies, ASFA and ASH, and shows how many questions you have left today

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-11-18.*
